Chiron Capital Management’s Sanofi SNY Stock Holding History

Chiron Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$644K	Buy	15,102 +6,500	+76%	+$290K	0.58%	52
2026 Q1	$414K	Buy	+8,602	New	+$401K	0.42%	62
2025 Q1	–	Sell	-7,204	Closed	-$347K	–	127
2024 Q4	$347K	Buy	+7,204	New	+$366K	0.33%	76
2023 Q2	–	Sell	-3,800	Closed	-$207K	–	128
2023 Q1	$207K	Buy	+3,800	New	+$185K	0.14%	107

Other funds holding SNY

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

FRM

Foundation Resource Management Little Rock, Arkansas $860M AUM 38.08% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

FBT

First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return

CCMINC

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return

Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return

Chiron Capital Management's SNY Position: Q2 2026 in Review

Chiron Capital Management increased its Sanofi (SNY) stake by 76% in Q2 2026, buying an estimated $290K and bringing the position to 15,102 shares worth $644K. The position accounts for 0.58% of the portfolio, ranked #52.

Chiron Capital Management first reported a position in SNY in Q1 2023 and has held it in 4 quarters since. 130 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Chiron Capital Management held 15,102 shares of Sanofi worth $644K as of Q2 2026.
Chiron Capital Management bought 6,500 Sanofi shares in Q2 2026, an estimated $290K.
Sanofi made up 0.58% of Chiron Capital Management's portfolio in Q2 2026, its #52 holding.
Chiron Capital Management first reported a position in Sanofi in Q1 2023 and has held it in 4 quarters since.
130 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.